Nicholas Babb is a seasoned biologist with extensive experience in neurodegeneration research, primarily at Eli Lilly and Company, where roles ranged from Scientist to Senior Principal Biologist between 2013 and 2024. Key contributions include the development of therapeutics and blood-brain barrier models for Alzheimer’s and Parkinson's diseases, collaborating with various laboratories and divisions. Additional experience includes a Microbiologist II position at the Indiana State Department of Health and a Research Assistant role at Texas A&M Health Science Center, where studies focused on Mycobacterium tuberculosis. Nicholas holds a Bachelor’s Degree in Chemistry with a Biochemistry emphasis from the University of Arkansas-Fort Smith.
This person is not in the org chart
This person is not in any teams
This person is not in any offices